M28 Capital Management LP — 13F Holdings & Portfolio

CIK 1807489 · latest 13F-HR filed 2026-05-14

M28 Capital Management LP manages $53.8M in 13F-reported U.S. long-equity assets across 9 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are WVE (61.83%), IVVD (22.35%), TGTX (5.46%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 0, added to 0, and trimmed 9.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$53.8M

Long-equity book

Holdings

9

Distinct positions

Period

2026-03-31

Filed 2026-05-14

Q/Q Activity

+0 / −0 / ↑0 / ↓9

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • No increased positions.
Show all 0

Top Trims

  • WAVE LIFE SCIENCES LTD-$63.0M -65.5%
  • INVIVYD INC-$10.8M -47.4%
  • FRACTYL HEALTH INC-$3.2M -79.2%
  • ARROWHEAD PHARMACEUTICALS IN-$2.2M -48.4%
  • TG THERAPEUTICS INC-$1.9M -39.1%
Show all 9

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 WAVE LIFE SCIENCES LTD WVE Y95308105 $33.3M 61.83% 4,588,284 SH
2 INVIVYD INC IVVD 00534A102 $12.0M 22.35% 9,248,250 SH
3 TG THERAPEUTICS INC TGTX 88322Q108 $2.9M 5.46% 88,354 SH
4 ARROWHEAD PHARMACEUTICALS IN ARWR 04280A100 $2.3M 4.29% 36,851 SH
5 PROQR THRAPEUTICS N V PRQR N71542109 $971.7K 1.81% 599,793 SH
6 FRACTYL HEALTH INC GUTS 35168W103 $849.7K 1.58% 1,856,117 SH
7 ROCKET PHARMACEUTICALS INC RCKT 77313F106 $754.9K 1.40% 210,871 SH
8 SILENCE THERAPEUTICS PLC SLN 82686Q101 $533.3K 0.99% 101,203 SH
9 CURIS INC CRIS 231269309 $155.9K 0.29% 284,889 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-14 $53.8M 9 0000902664-26-002442
2025-12-31 2026-02-13 $137.6M 9 0000902664-26-000993
2025-09-30 2025-11-13 $68.0M 9 0000902664-25-004910